{
    "code": "01019900",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01019900",
    "time": "2020-02-25 02:54:30",
    "許可證字號": "衛署藥製字第019900號",
    "註銷狀態": "已註銷",
    "註銷日期": "77\/07\/19",
    "註銷理由": "安用科更新資料",
    "有效日期": "75\/12\/21",
    "發證日期": "68\/12\/21",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00101990001",
    "中文品名": "安利肌注射液（奧菲那特林）",
    "英文品名": "ORELAX INJECTION (ORPHENADRINE) &quot;LITA&quot;",
    "適應症": "肌肉僵直、疼痛、痙攣的解除、局部肌肉損傷、腰背痛、斜頸顫動性癱瘓的復元",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產",
        "申請商名稱": "0701010200  利達製藥股份有限公司",
        "申請商地址": "台中縣大甲鎮中山路一段９０６號",
        "主製造廠": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208003420",
            "成分名稱": "ORPHENADRINE CITRATE",
            "含量描述": "60",
            "含量": "60.0000000000",
            "單位": "MG"
        }
    ]
}